Select an Agent to Talk

How it works
Process of making more profit by mutual fund investing
Select right scheme
Now when you want to get going, start by selecting the right scheme.
Create scheme cart
Create a cart of selected schemes that suits your requirements.
Approve & invest online
Invest through our online portal and track your investment.
Our investment process consist of
We offer wide range of services and products to help
our clients grow and thrive
RiskOmeter
We help you by providing complete list of MF schemes according to SEBI updated riskometer.
Safe and Secure Txn
We execute your order through our registered transaction platform with 100% safety.
Investing in SIP is simple and quick

Estimate your requirements, select scheme and start a SIP

How much do you want to invest ?
Investment Period
Expected Annual Returns (%)
Adjust for inflation ?
Wealth Gain
"{{ wealthgainindian }}"
Amount Invested
"{{ amountinvestedindian }}"
Expected
Maturity Amount
"{{ futurevalueindian }}"
If you start investing with "{{ amountindian }}" per month, we can help you grow it to
"{{ futurevalueindian }}"*
How much do you want to invest as lump sum?
Investment Period
Expected Annual Returns (%)
Adjust for inflation ?
Wealth Gain
"{{ wealthgainindian }}"
Amount Invested
"{{ amountinvestedindian }}"
Expected
Maturity Amount
"{{ futurevalueindian }}"
If you invest "{{ amountindian }}" as lump sum, we can help you grow it to
"{{ futurevalueindian }}"*
Reason to choose us
Best Team of Experts
We are the best team of experts to help you to resolve your queries.
Customize Investment
Choose the schemes that suits your requirements the best!
Secure Online Transactions
Direct Payment method, no mediator account is required.
Online Portfolio Tracking
Track your portfolio online from anywhere-anytime.
You can get in touch with us anytime.
Call at 7503000740
Reason to choose us image
Understanding Mutual Fund is now easier !
Watch the videos to know the basics of mutual funds.

Stay updated with Market Statistic and News

We keep our tab on various news and performance in Mutual Fund Industry, to deliver the very best to our clients.

SRN Capital App
Changing the way you invest
Invest your money on the go
Experience the new way of investing through our Smart Featured App enabled with transaction capability. You can track the performance of your investments in real time and you will also get to know the daily change in your investments.
  • You can create your free account
  • You can transact online
  • You can track your portfolio 24x7

Latest Market News

Godfrey Phillips Q2 profit down 37% to Rs 190 cr; revenue up twofold at Rs 4,198 cr

Godfrey Phillips India Ltd reported a significant 37.73 percent decrease in net profit for the September quarter, primarily driven by a substantial tax increase from the previous fiscal year. Despite this, the company's total consolidated income surged to Rs 8,139.64 crore during the first half of FY27. To counteract the volumetric impact from rising taxes, a tactical pricing strategy was implemented.

Apple seeks about $7 billion from bond sale, Bloomberg News reports

Apple is seeking about $7 billion from a US-dollar bond offering, Bloomberg News reported on Thursday, citing people familiar with the matter. The iPhone maker is the latest major tech company to tap debt markets as the sector raises large sums to fund AI expansion.

Qualcomm shares 9% slump as weak smartphone chip sales overshadow data-center momentum

Qualcomm's shares dropped significantly in early trading following disappointing smartphone chip sales. The company's largest business segment faced a 26% revenue decline, leading to lower overall chip sales. While Qualcomm's investments in data-center and automotive chips strengthen its growth potential, analysts remain skeptical about immediate earnings. Brokerages have reduced their price targets on Qualcomm's stock after recent results were released.

Elon Musk gambled $445 million to boost Republicans in midterms and came up short

Elon Musk's hefty USD 445 million investment in Republican candidates did not yield the desired electoral success, as Republicans faced significant losses, ceding control of Congress. This setback has prompted Democrats to contemplate investigating Musk's business operations. Critics have denounced his financial influence in politics, highlighting the risks of affluent individuals shaping policy. Anticipated changes in Texas's Democratic leadership suggest intensified scrutiny of Musk's ties to the state.

Emerging market outflows hit $33.8 billion, US midterms offer some relief

October witnessed an alarming withdrawal of $33.8 billion by foreign investors from emerging markets, the largest since March. Almost all of this outflow consisted of equities, severely impacting Taiwan. While Emerging Asia grappled with major losses, Latin America encountered minimal setbacks amid election-related volatility. Additionally, Chinese stocks continued to see foreign sell-offs for the fifth consecutive month.

Nasdaq tumbles over 3% as tech stocks extend selloff after Democrats sweep midterms; Tesla plunges 9%, chipmakers slide

US stocks faced a sharp decline on Thursday, particularly in technology shares, amid concerns over regulatory scrutiny. The Nasdaq Composite fell over 3%, reversing optimism following the Democrats' midterm election victories. Key companies including Nvidia, Advanced Micro Devices, and Tesla were among the hardest hit. Investors expressed worries about the implications of stronger Democratic control on the artificial intelligence industry.

Signature Global clocks Rs 67 cr profit in Q2 vs loss yr ago, revenue rises over 2-fold

Signature Global Ltd has reported a consolidated net profit of Rs 66.90 crore for the quarter ending September, marking a significant turnaround from last year's net loss of Rs 46.86 crore. With total income soaring from Rs 372.51 crore to Rs 870.70 crore, the company's chairman highlighted a robust demand for quality housing and its strong financial health. Since its establishment, Signature Global has successfully delivered 19.

Glenmark Pharma Q2 Results: Net profit plunges 56% to Rs 264 crore, revenue down at Rs 4,247 cr

Glenmark Pharmaceuticals experienced a 56.78 percent drop in consolidated profit after tax during the September quarter. Total revenue from operations decreased to Rs 4,247.32 crore compared to the previous year. The company's total expenses also decreased during the same period, indicating some operational efficiency. A subsidiary of Glenmark Pharma entered into a settlement for USD 15 million with Humana Inc.

Loading Live Market Data...